Possible Destructive Role of Antioxidant Enzyme Antibodies in Cardiovascular Lesions in Patients With Systemic Scleroderma

doi 10.18411/978-5-907109-24-7-2018-xxxv-74-81
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Планета

Related search

Antiphospholipid Antibodies in Patients With Scleroderma: Prevalence and Clinical Significance

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Initial Predictors of Survival in Patients With Systemic Sclerosis (Scleroderma).

Keio Journal of Medicine
Medicine
1992English

Investigation of the Skin Collagen Synthetic Activity in Patients With Systemic Scleroderma and in Experimental Scleroderma

The KITAKANTO Medical Journal
1979English

Systemic Sclerosis Complicated With Localized Scleroderma-Like Lesions Induced by Köbner Phenomenon

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2018English

Anti-C1q Antibodies in Scleroderma

British Journal of Dermatology
DermatologyMedicine
2019English

Antimyenteric Neuronal Antibodies in Scleroderma.

Journal of Clinical Investigation
Medicine
1994English

Immunological Features in Anti-U1-Ribonucleoprotein Antibody Positive Patients With Systemic Scleroderma

Modern Rheumatology Journal
2020English

The Problem of Activity in Systemic Scleroderma

Modern Rheumatology Journal
2013English

Are Anti-Ro52 Antibodies Associated With Pulmonary Involvement in Scleroderma?

Journal of Pulmonary & Respiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy